Novavax Inc Stock Forecast:
According to six analysts, the average target price for Novavax Inc over the next 12 months is $51.71, and the average analyst rating is Buy. Stock Target Advisor‘s analysis is Slightly Bearish based on four positive signals and five negative signals. Novavax Inc’s stock price was $8.96 at the last closing, having decreased by 0.88% over the past week, increased by 50.59% over the past month, and decreased by 83.59% over the past year.
Analysts Coverage Change:
TD Cowan Downgrades Novavax Inc. to a “Market Perform” rating and lowers the target price to $10 from $55 on the company’s stock.
Novavax Inc. stock has a high market capitalization, making it one of the largest entities in its sector and is among the top quartile, indicating stability. It has demonstrated superior risk-adjusted returns compared to its sector peers and is in the top quartile. Novavax has also shown top quartile revenue growth in the previous five years compared to its sector and has a high Gross Profit to Asset Ratio, which is a popular measure among value investors for showing superior returns in the long run.
Novavax Inc stock has several concerning factors that may make it less attractive to investors. Firstly, it has a high level of volatility in its total returns over the past 5 years, which may be too risky for some investors. Additionally, the stock appears overpriced compared to its peers on a price to book value basis. The company has negative total cash flow and negative total free cash flow in the most recent four quarters. Finally, Novavax Inc has shown below median earnings growth over the past 5 years compared to its sector.
FA Score (Fundamental Analysts):
The fundamental analysis of Novavax Inc. is “Slightly Bearish” with a FA score of 4.4 out of 10, where 0 is very bearish and 10 is very bullish.